Predictive Findings of Visual Outcome in Spectral Domain Optical Coherence Tomography after Ranibizumab Treatment in Age-related Macular Degeneration
3
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: To investigate which spectral domain optical coherence tomography (SD-OCT) findings predict visual outcome after anti-vascular endothelial growth factor (VEGF) treatment in neovascular age-related macular degeneration (NV-AMD). Methods: We reviewed the medical records of patients with treatment-naïve NV-AMD who underwent three or more consecutive anti-VEGF injections. The patients were divided into three groups according to their changes of visual acuity (VA); improved (group I), static (group S), or worsened (group W). We assessed the incidences and values of all available SD-OCT findings of these groups, compared these findings between the three groups and compared the initial values with the post-treatment values. Results: Better initial VA and longer external limiting membrane (ELM) length were associated with less change in VA after anti-VEGF treatment. The initial VA was mildly correlated with initial photoreceptor inner and outer segment junction (IS/OS) length and initial ELM length. The final VA was also mildly correlated with the final IS/ OS length and the final ELM length. VA was significantly changed after anti-VEGF treatment in groups W and I. With regard to incidence, disruption of the IS/OS (IS/OS-D), disruption of the ELM (ELM-D) and ELM length differed significantly between the three groups, particularly ELM-D. The incidences of IS/OS-D and ELM-D in group I were significantly lower than those in groups S and W, and those in group S were also lower than those in group W. The ELM length in group I was significantly longer than it was in groups S and W, and the ELM length in group S was longer than that for group W. However, these three findings did not change after the anti-VEGF treatment. Conclusions: Initial IS/OS-D, ELM length and particularly ELM-D can be useful predictors of the visual outcome after anti-VEGF treatment in NV-AMD patients.
Abstract
Purpose: To investigate which spectral domain optical coherence tomography (SD-OCT) findings predict visual outcome after anti-vascular endothelial growth factor (VEGF) treatment in neovascular age-related macular degeneration (NV-AMD). Methods: We reviewed the medical records of patients with treatment-naïve NV-AMD who underwent three or more consecutive anti-VEGF injections. The patients were divided into three groups according to their changes of visual acuity (VA); improved (group I), static (group S), or worsened (group W). We assessed the incidences and values of all available SD-OCT findings of these groups, compared these findings between the three groups and compared the initial values with the post-treatment values. Results: Better initial VA and longer external limiting membrane (ELM) length were associated with less change in VA after anti-VEGF treatment. The initial VA was mildly correlated with initial photoreceptor inner and outer segment junction (IS/OS) length and initial ELM length. The final VA was also mildly correlated with the final IS/ OS length and the final ELM length. VA was significantly changed after anti-VEGF treatment in groups W and I. With regard to incidence, disruption of the IS/OS (IS/OS-D), disruption of the ELM (ELM-D) and ELM length differed significantly between the three groups, particularly ELM-D. The incidences of IS/OS-D and ELM-D in group I were significantly lower than those in groups S and W, and those in group S were also lower than those in group W. The ELM length in group I was significantly longer than it was in groups S and W, and the ELM length in group S was longer than that for group W. However, these three findings did not change after the anti-VEGF treatment. Conclusions: Initial IS/OS-D, ELM length and particularly ELM-D can be useful predictors of the visual outcome after anti-VEGF treatment in NV-AMD patients.
참고문헌 (13)
- Dadgostar H, "The evolving role of vascular endothelial growth factor inhibitors in the treatment of neovascular age-related macular degeneration", Eye, 22, pp.761~767 (2008)
- Joeres S, "Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration", Ophthalmology, 115, pp.347e2~354e2 (2008)
- Kaiser PK, "Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration", Ophthalmology, 114, pp.1868~1875 (2007)
- "Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:one-year results of 2 randomized clinical trials: TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group", Arch Ophthalmol, 117, pp.1329~1345 (1999)
- Verteporfin In Photodynamic Therapy Study Group, "Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization: verteporfin in photodynamic therapy report 2", Am J Ophthalmol, 131, pp.541~560 (2001)
- Bressler NM, "Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:two-year results of 2 randomized clinical trials-tap report 2", Arch Ophthalmol, 119, pp.198~207 (2001)
- Hayashi H, "Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration", Am J Ophthalmol, 148, pp.83~89e1 (2009)
- Sayanagi K, "Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration", Br J Ophthalmol, 93, pp.622~626 (2009)
- Hagan MJ, "Histology of the human eye: an atlas and textbook", pp.393~522 (1971), Saunders
- Shin HJ, "Association between foveal microstructure and visual outcome in age-related macular degeneration", Retina, 31, pp.1627~1636 (2011)
- Oishi A, "The significance of external limiting membrane status for visual acuity in age-related macular degeneration", Am J Ophthalmol, 150, pp.27e1~32e1 (2010)
- Moutray T, "Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation", Br J Ophthalmol, 92, pp.361~364 (2008)
- Keane PA, "Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration", Ophthalmology, 115, pp.2206~2214 (2008)